Elicio Therapeutics, Inc. (ELTX)

Elicio Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	20.61	17.62	12.89	6.16	88.76	34.61
Cash & Short-Term Investments	20.61	17.62	12.89	6.16	88.76	34.61
Cash Growth	-20.78%	36.64%	109.45%	-93.06%	156.47%	521.20%
Other Receivables	-	-	-	-	0.81	-
Total Trade Receivables	-	-	-	-	0.81	-
Other Current Assets	0.85	3.08	3.45	4.56	1.69	7.69
Total Current Assets	21.47	20.69	16.35	10.72	91.25	42.3
Net Property, Plant & Equipment	5.35	6.19	7.28	8.5	4.44	4.23
Long-Term Investments	-	-	-	-	0.72	0.82
Other Long-Term Assets	1.47	1.3	3.52	3.45	0.11	-
Total Assets	28.28	28.18	27.15	22.66	96.51	47.35
Accounts Payable	0.32	1.04	4.37	2.81	4.71	5.58
Accrued Expenses	5.21	8.42	3.76	1.94	3.22	6.67
Short-Term Debt	-	-	-	-	-	79.95
Current Portion of Leases	0.98	0.9	0.91	0.69	0.89	0.61
Unearned Revenue	-	1.17	0.69	1.44	2.3	3.94
Other Current Liabilities	3.88	2.83	0.04	-	0.17	10.7
Total Current Liabilities	6.52	11.52	9.76	6.87	11.3	107.45
Long-Term Debt	9.72	20.03	-	-	-	0.64
Long-Term Leases	4.36	5.11	6.01	6.79	3.48	3.85
Other Long-Term Liabilities	-	-	-	0.09	0.24	25.87
Total Long-Term Liabilities	14.08	25.14	6.01	6.88	3.71	30.35
Total Liabilities	24.47	39.49	15.77	13.75	15.01	137.8
Common Stock	0.17	0.11	0.1	0	0.3	0.16
Treasury Stock	-0.15	-0.15	-0.15	-	-	-1.85
Additional Paid-in Capital	229.78	183	153.83	4.86	296.45	72.14
Accumulated Other Comprehensive Income	-0.03	-0.18	-0.2	-	-0.1	-0.33
Retained Earnings	-225.95	-194.1	-142.2	-107.01	-215.14	-160.56
Total Common Shareholders' Equity	3.82	-11.31	11.37	-102.15	81.51	-90.45
Minority Interest	-	-	-	111.06	-	-
Shareholders' Equity	3.82	-11.31	11.37	8.92	81.51	-90.45
Total Liabilities & Equity	28.28	28.18	27.15	22.66	96.51	47.35
Total Debt	15.06	26.04	6.92	7.48	4.37	85.04
Net Cash (Debt)	5.55	-8.42	5.98	-1.33	84.39	-50.44
Net Cash Per Share	0.37	-0.69	1.18	-4.19	29.88	-34.16
Book Value	3.82	-11.31	11.37	-102.15	81.51	-90.45
Book Value Per Share	0.26	-0.93	2.25	-323.25	28.86	-61.27
Tangible Book Value	3.82	-11.31	11.37	-102.15	81.51	-90.45
Tangible Book Value Per Share	0.26	-0.93	2.25	-323.25	28.86	-61.27

Updated Sep 30, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q